Eli Lilly , which has added more than $300 billion in market value this year, largely on the back of investment optimism for ...
Eli Lilly reported third-quarter results before the market opened on Wednesday. Management missed Wall Street estimates and lowered earnings guidance for 2024. Sales of Zepbound and Mounjaro ...
The S&P 500 slipped 0.3 percent after drifting between small gains and losses several times, though it's still near its ...
Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two ...
The Indianapolis-based drugmaker missed expectations on sales of two popular drugs, diabetes treatment Mounjaro and ...
LLY had $11.4 billion in revenue for the quarter (up 20% versus Q3 figures from last year), with a net income of $970 million ...
Eli Lilly is set to report Q3 earnings Wednesday, as the pharma giant continues to gain market share in the weight loss drug ...
U.S. stock indexes are edging higher Wednesday following a strong profit report from Google's parent company, though drops for Eli Lilly and others are keeping Wall Street in check.
US stock indexes are wavering following a strong profit report from Google’s parent company, while drops for Eli Lilly and ...
The Canadian Press on MSN1d
Stock market today: Rising tech stocks send Nasdaq toward recordRising technology stocks are sending the Nasdaq composite toward a record on Tuesday, but trading is mixed along the rest of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback